# US 2021/0079377 A1 · Method of Isolating Exosomes Using Encapsulation And Aqueous Micellar System

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0079377 A1
- Document ID: US20210079377A1
- Status: Published application
- Kind: A1
- Application number: 16/961,248
- Filed: 2019-01-18
- Published: 2021-03-18
- Earliest claimed: 2018-01-19
- Assignees: Phase Scientific International, Ltd.
- Applicants: Phase Scientific International, Ltd.
- Inventors: Yin To CHIU
- Web page: https://patentgrep.com/patent/US20210079377A1

## CPC

- C12N 15/1006: {by means of a solid support carrier, e.g. particles, polymers}
- C12Q 1/6806: Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence)
- C07K 1/145: {by extraction or solubilisation}
- G01N 1/4044: {by chemical techniques; Digestion; Chemical decomposition}
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

The present disclosure relates to a method/system for preparing encapsulated exosomes from a biological sample containing exosomes, said method comprising: a) dispersing inorganic oxide particles into a buffer solution comprising a polymer and a biological sample comprising exosomes, b) allowing the polymer to react with the inorganic oxide particles to form capsules, wherein the exosomes are inside the capsules. The present disclosure also relates to a method/system for isolating and purifying encapsulated exosomes, said method comprising: a) preparing an aqueous micellar system comprising at least one surfactant, and at least one salt; b) mixing a biological sample containing encapsulated exosomes with the aqueous micellar system from step a); c) allowing the aqueous micellar system to phase separate, wherein the surfactant partitions substantially into one phase, and the other phase has a lower concentration of surfactant; and d) obtaining the encapsulated exosomes from the capsule-rich phase.

## Claims

### Claim 1

A method for isolating exosomes from a biological sample, comprising the steps of:
a. dispersing inorganic oxide particles having reactive functional groups into a buffer solution, said solution comprising a polymer and a biological sample comprising exosomes, wherein the polymer reacts with said reactive functional groups to form capsules encapsulating said exosomes;
b. isolating the capsules, and mixing said capsules with an aqueous micellar system comprising at least one salt and at least one surfactant;
c. allowing phase separation of said aqueous micellar system to give a first phase and a second phase, wherein the first phase has a substantially higher concentration of said surfactant than the second phase, wherein the capsules are concentrated in one of the two phases;
d. isolating the capsules from the capsule-rich phase; and
e. adding a buffer solution of metal ions to the isolated capsules to release the exosomes encapsulated in said isolated capsules.

### Claim 2 (depends on 1)

The method of claim 1, wherein said polymer has a Hydrophile-Lipophile Balance (HLB) value of no more than 6.0.

### Claim 3 (depends on 1)

The method of claim 1, wherein said reactive functional groups are selected from the group consisting of epoxy groups, carboxylic groups, unsaturated groups, amine groups, amine-terminated groups and alkylamine groups.

### Claim 4 (depends on 1)

The method of claim 1, wherein said polymer forms a network with the inorganic oxide particles, thereby encapsulating the exosomes.

### Claim 5 (depends on 1)

The method of claim 1, wherein said polymer is polyethylene glycol (PEG).

### Claim 6 (depends on 1)

The method of claim 1, wherein said polymer is polyethylene glycol (PEG) having a molecular weight ranging from 1000 Da to 5000 Da.

### Claim 7 (depends on 1)

The method of claim 1, wherein said inorganic oxide particles have an average particle diameter (d50) of 0.25 to 1 μm.

### Claim 8 (depends on 1)

The method of claim 1, wherein said inorganic oxide particles have an average particle diameter (d50) of 50 to 100 nm.

### Claim 9 (depends on 1)

The method of claim 1, wherein said oxide particles are metal oxides, wherein the metal in said metal oxides is selected from Group III, Group IVB and Group VIII of the Periodic Table.

### Claim 10 (depends on 1)

The method of claim 1, wherein the polymer reacts to an extent ranging from 3% to 60%.

### Claim 11 (depends on 1)

The method of claim 1, wherein the polymer reacts to an extent ranging from 3% to 30%.

### Claim 12 (depends on 1)

The method of claim 1, wherein said surfactant is a non-ionic surfactant.

### Claim 13 (depends on 1)

The method of claim 1, wherein said surfactant is selected from the group consisting of alkylphenol polyoxyethylene ethers, polyoxyethylene ethers, polyoxytheylene esters, polyoxyethylene sorbitan esters, polyoxyethylene substituted sugars, sugar surfactants and non-ionic surfactants.

### Claim 14 (depends on 1)

The method of claim 1, wherein the surfactant has a concentration in the range of 0.001% (w/w) to 90% (w/w) of the total weight of said aqueous micellar system.

### Claim 15 (depends on 1)

The method of claim 1, wherein said salt is a kosmotropic salt, chaotropic salt or inorganic salt.

### Claim 16 (depends on 15)

The method of claim 15, wherein said inorganic salt has a cation selected from the group consisting of straight or branched trimethyl ammonium, triethyl ammonium, tripropyl ammonium, tributyl ammonium, tetramethyl ammonium, tetraethyl ammonium, tetrapropyl ammonium and tetrabutyl ammonium.

### Claim 17 (depends on 16)

The method of claim 16, wherein said inorganic salt has an anion selected from the group consisting of phosphate, sulphate, nitrate, chloride and hydrogen carbonate.

### Claim 18 (depends on 1)

The method of claim 1, wherein said salt is selected from the group consisting of sodium chloride, sodium phosphate, disodium phosphate, potassium phosphate, sodium sulphate, potassium citrate, ammonium sulphate, sodium citrate, sodium acetate, ammonium acetate, and combinations thereof.

### Claim 19 (depends on 1)

The method of claim 1, wherein the salt in said aqueous micellar system has a concentration of 0.001% up to the point of saturation.

### Claim 20 (depends on 1)

The method of claim 1, wherein said metal ions are in a buffer comprising tris(hydroxymethyl)aminomethane (Tris), ethylenediamine-tetraacetic acid (EDTA) or polyadenylic acid.

### Claim 21 (depends on 1)

The method of claim 1, wherein the metal of said metal ions is selected from Groups 1B, 2A, 2B, 3A and 8B of the Periodic Table.

### Claim 22 (depends on 1)

The method of claim 1, wherein said metal ions are selected from the group consisting of Cu(II), Zn(II), Mg (II), Ca (II), Ni(III), Fe (II), Fe(III) and Al(III).
